Copyright Reports & Markets. All rights reserved.

Global and United States Infectious Disease Diagnostic Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Infectious Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Instruments
    • 1.2.3 Consumables
    • 1.2.4 Software and Services
  • 1.3 Market by Application
    • 1.3.1 Global Infectious Disease Diagnostic Market Share by Application: 2020 VS 2026
    • 1.3.2 Hepatitis B virus (HBV)
    • 1.3.3 Hepatitis C virus (HCV)
    • 1.3.4 Acquired Immunodeficiency Syndrome (AIDS)
    • 1.3.5 Tuberculosis (TB)
    • 1.3.6 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
    • 1.3.7 Human Papillomavirus (HPV) infection
    • 1.3.8 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Infectious Disease Diagnostic Market Perspective (2015-2026)
  • 2.2 Global Infectious Disease Diagnostic Growth Trends by Regions
    • 2.2.1 Infectious Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Infectious Disease Diagnostic Historic Market Share by Regions (2015-2020)
    • 2.2.3 Infectious Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Infectious Disease Diagnostic Players by Market Size
    • 3.1.1 Global Top Infectious Disease Diagnostic Players by Revenue (2015-2020)
    • 3.1.2 Global Infectious Disease Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.2 Global Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Infectious Disease Diagnostic Revenue
  • 3.4 Global Infectious Disease Diagnostic Market Concentration Ratio
    • 3.4.1 Global Infectious Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostic Revenue in 2019
  • 3.5 Key Players Infectious Disease Diagnostic Area Served
  • 3.6 Key Players Infectious Disease Diagnostic Product Solution and Service
  • 3.7 Date of Enter into Infectious Disease Diagnostic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Diagnostic Breakdown Data by Type (2015-2026)

  • 4.1 Global Infectious Disease Diagnostic Historic Market Size by Type (2015-2020)
  • 4.2 Global Infectious Disease Diagnostic Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Diagnostic Breakdown Data by Application (2015-2026)

  • 5.1 Global Infectious Disease Diagnostic Historic Market Size by Application (2015-2020)
  • 5.2 Global Infectious Disease Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Infectious Disease Diagnostic Market Size (2015-2026)
  • 6.2 North America Infectious Disease Diagnostic Market Size by Type (2015-2020)
  • 6.3 North America Infectious Disease Diagnostic Market Size by Application (2015-2020)
  • 6.4 North America Infectious Disease Diagnostic Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Infectious Disease Diagnostic Market Size (2015-2026)
  • 7.2 Europe Infectious Disease Diagnostic Market Size by Type (2015-2020)
  • 7.3 Europe Infectious Disease Diagnostic Market Size by Application (2015-2020)
  • 7.4 Europe Infectious Disease Diagnostic Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Infectious Disease Diagnostic Market Size (2015-2026)
  • 8.2 China Infectious Disease Diagnostic Market Size by Type (2015-2020)
  • 8.3 China Infectious Disease Diagnostic Market Size by Application (2015-2020)
  • 8.4 China Infectious Disease Diagnostic Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Infectious Disease Diagnostic Market Size (2015-2026)
  • 9.2 Japan Infectious Disease Diagnostic Market Size by Type (2015-2020)
  • 9.3 Japan Infectious Disease Diagnostic Market Size by Application (2015-2020)
  • 9.4 Japan Infectious Disease Diagnostic Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Infectious Disease Diagnostic Market Size (2015-2026)
  • 10.2 Southeast Asia Infectious Disease Diagnostic Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Infectious Disease Diagnostic Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Infectious Disease Diagnostic Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Infectious Disease Diagnostic Introduction
    • 11.1.4 Roche Revenue in Infectious Disease Diagnostic Business (2015-2020))
    • 11.1.5 Roche Recent Development
  • 11.2 BioMrieux SA
    • 11.2.1 BioMrieux SA Company Details
    • 11.2.2 BioMrieux SA Business Overview
    • 11.2.3 BioMrieux SA Infectious Disease Diagnostic Introduction
    • 11.2.4 BioMrieux SA Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.2.5 BioMrieux SA Recent Development
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Business Overview
    • 11.3.3 Bio-Rad Laboratories Infectious Disease Diagnostic Introduction
    • 11.3.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.3.5 Bio-Rad Laboratories Recent Development
  • 11.4 Danaher Corporation
    • 11.4.1 Danaher Corporation Company Details
    • 11.4.2 Danaher Corporation Business Overview
    • 11.4.3 Danaher Corporation Infectious Disease Diagnostic Introduction
    • 11.4.4 Danaher Corporation Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.4.5 Danaher Corporation Recent Development
  • 11.5 Becton
    • 11.5.1 Becton Company Details
    • 11.5.2 Becton Business Overview
    • 11.5.3 Becton Infectious Disease Diagnostic Introduction
    • 11.5.4 Becton Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.5.5 Becton Recent Development
  • 11.6 Dickinson and Company
    • 11.6.1 Dickinson and Company Company Details
    • 11.6.2 Dickinson and Company Business Overview
    • 11.6.3 Dickinson and Company Infectious Disease Diagnostic Introduction
    • 11.6.4 Dickinson and Company Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.6.5 Dickinson and Company Recent Development
  • 11.7 Cepheid
    • 11.7.1 Cepheid Company Details
    • 11.7.2 Cepheid Business Overview
    • 11.7.3 Cepheid Infectious Disease Diagnostic Introduction
    • 11.7.4 Cepheid Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.7.5 Cepheid Recent Development
  • 11.8 Abbott
    • 11.8.1 Abbott Company Details
    • 11.8.2 Abbott Business Overview
    • 11.8.3 Abbott Infectious Disease Diagnostic Introduction
    • 11.8.4 Abbott Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.8.5 Abbott Recent Development
  • 11.9 DiaSorin.
    • 11.9.1 DiaSorin. Company Details
    • 11.9.2 DiaSorin. Business Overview
    • 11.9.3 DiaSorin. Infectious Disease Diagnostic Introduction
    • 11.9.4 DiaSorin. Revenue in Infectious Disease Diagnostic Business (2015-2020)
    • 11.9.5 DiaSorin. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Infectious Disease Diagnostic Scope and Market Size
    Infectious Disease Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Instruments
    Consumables
    Software and Services

    Market segment by Application, split into
    Hepatitis B virus (HBV)
    Hepatitis C virus (HCV)
    Acquired Immunodeficiency Syndrome (AIDS)
    Tuberculosis (TB)
    Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
    Human Papillomavirus (HPV) infection
    Others

    Based on regional and country-level analysis, the Infectious Disease Diagnostic market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Infectious Disease Diagnostic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Roche
    BioMrieux SA
    Bio-Rad Laboratories
    Danaher Corporation
    Becton
    Dickinson and Company
    Cepheid
    Abbott
    DiaSorin.

    Buy now